2019 annual financial data
Bolt Biotherapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -12,252.56%.
Operating income was -30,969,000 USD and net income was -30,487,000 USD.
Operating cash flow was -26,343,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 215,000 USD
- Operating income
- -30,969,000 USD
- Net income
- -30,487,000 USD
- Operating cash flow
- -26,343,000 USD